WO1990013660A3 - Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives - Google Patents

Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives Download PDF

Info

Publication number
WO1990013660A3
WO1990013660A3 PCT/US1990/002558 US9002558W WO9013660A3 WO 1990013660 A3 WO1990013660 A3 WO 1990013660A3 US 9002558 W US9002558 W US 9002558W WO 9013660 A3 WO9013660 A3 WO 9013660A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibodies
human monoclonal
sero
gram
negative bacteria
Prior art date
Application number
PCT/US1990/002558
Other languages
English (en)
Other versions
WO1990013660A2 (fr
Inventor
Alois B Lang
James W Larrick
Stanley J Cryz
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of WO1990013660A2 publication Critical patent/WO1990013660A2/fr
Publication of WO1990013660A3 publication Critical patent/WO1990013660A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Static Random-Access Memory (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Des compositions prophylactiques ou thérapeutiques utiles pour traiter des infections bactériémiques comprennent des anticorps monoclonaux humains qui se lient à Pseudomonas aeruginosa, Klebsiella et E. coli, ensemble ou séparément. Des procédés d'utilisation de la composition afin de traiter des patients souffrant d'infections bactériémiques sont également décrits.
PCT/US1990/002558 1989-05-09 1990-05-08 Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives WO1990013660A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34959489A 1989-05-09 1989-05-09
US349,594 1989-05-09

Publications (2)

Publication Number Publication Date
WO1990013660A2 WO1990013660A2 (fr) 1990-11-15
WO1990013660A3 true WO1990013660A3 (fr) 1990-12-13

Family

ID=23373107

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/002558 WO1990013660A2 (fr) 1989-05-09 1990-05-08 Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives

Country Status (3)

Country Link
JP (1) JPH0329196A (fr)
AU (1) AU5675790A (fr)
WO (1) WO1990013660A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370872A (en) * 1991-08-12 1994-12-06 Swiss Serum And Vaccine Institute Berne Escherichia coliO-polysaccharide-protein conjugate vaccine
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
EP2098536A1 (fr) 2008-03-05 2009-09-09 4-Antibody AG Isolation et identification de protéines de liaison spécifiques à des antigènes ou à des ligands

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001807A1 (fr) * 1984-09-07 1986-03-27 Technology Licence Company Limited Anticorps monoclonaux et leur utilisation
GB2185266A (en) * 1985-12-10 1987-07-15 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypes
GB2186592A (en) * 1986-02-07 1987-08-19 Genetic Systems Corp Cross-protective human monoclonal antibody compositions
EP0338395A2 (fr) * 1988-04-19 1989-10-25 BEHRINGWERKE Aktiengesellschaft Anticorps monoclonaux contre Pseudomonas aeruginosa, leur production et utilisation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001807A1 (fr) * 1984-09-07 1986-03-27 Technology Licence Company Limited Anticorps monoclonaux et leur utilisation
GB2185266A (en) * 1985-12-10 1987-07-15 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypes
GB2186592A (en) * 1986-02-07 1987-08-19 Genetic Systems Corp Cross-protective human monoclonal antibody compositions
EP0338395A2 (fr) * 1988-04-19 1989-10-25 BEHRINGWERKE Aktiengesellschaft Anticorps monoclonaux contre Pseudomonas aeruginosa, leur production et utilisation

Also Published As

Publication number Publication date
WO1990013660A2 (fr) 1990-11-15
AU5675790A (en) 1990-11-29
JPH0329196A (ja) 1991-02-07

Similar Documents

Publication Publication Date Title
BG110703A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION
WO1997017446A3 (fr) ANTICORPS HUMANISES DIRIGES CONTRE LA gp39 D'ORIGINE HUMAINE, COMPOSITIONS CONTENANT CES ANTICORPS ET LEUR UTILISATION THERAPEUTIQUE
IL189629A0 (en) Compositions containing human ctla-4 antibodies
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
HK1027802A1 (en) Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
SE8605295D0 (sv) Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes
WO1999025367A3 (fr) Traitement de troubles hematologiques
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
CA2070685A1 (fr) Methode de traitement des affections douloureuses, inflammatoires ou allergiques
WO2006009525A3 (fr) Peptides de liaison specifiques de l'exopolysaccharide mucoide de p. aeruginosa
ES2009140A6 (es) Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.
MD1521G2 (ro) Metode de inhibare a formării de trombi, metode de tratament al stărilor trombotice, compoziţii farmaceutice şi trusă pentru tratamentul stărilor trombotice
WO2001040473A3 (fr) Antigenes de pseudomonas aeruginosa
CA2316411A1 (fr) Anticorps humanises monoclonaux protegeant contre les maladies induites par les toxines de shiga
WO1990013660A3 (fr) Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives
AU7792294A (en) Antibacterial composition containing multimeric alpha-lactalbumin
IE871769L (en) Fluorooxirane carboxylates
EP0441395A3 (en) Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
GR890100183A (en) Process for the preparation of topically applied gold organic complex
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
EP0321094A3 (fr) Traitement des inhibiteurs de facteur VIII

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB IT LU ML MR NL SE SN TD TG

NENP Non-entry into the national phase

Ref country code: CA